• 1
    Warren K. Blood flukes (schistosomes) and liver flukes. In: McLntyre, N, Benhamou, JP, Bircher, J, Rizzetto, M, Rhodes, J, eds. Oxford Textbook of Clinical Hepatology. New York: Oxford University Press, 1991: 71421.
  • 2
    El-Khoby T, Galal N, Fenwick A et al. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 2000;62 (Suppl. 2):8899.
  • 3
    Capron A, Dessaint JP. Immunologic aspects of schistosomiasis. Ann Rev Med 1992;43: 20918.
  • 4
    Sabin EA, Pearce EJ. Early IL-4 production by non-CD4 cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J Immunol 1995;155: 484455.
  • 5
    Estaquier J, Marguerite M, Sahuc F, Bessis N, Auriault C, Ameisen JC. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni infection. Eur Cytokine Netw 1997;8: 15360.
  • 6
    Malaquias KC, Falcao PL, Silveira AM et al. Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5, and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol 1997;46: 3938.DOI: 10.1046/j.1365-3083.1997.d01-136.x
  • 7
    Mousa AH. Hepatosplenic schistosomiasis (endemic hepato-splenomegaly). In: Compiled Review on Schistosomiasis. Cairo, Egypt: Nat Inf Doc (NIDOG), 1976: 14555.
  • 8
    Mikhail IA, Higashi NS, Mansour NS, Ednan DC, Elwan SH. Salmonella paratyphi A in hamsters concurrently infected withSchistosoma mansoni. Am J Trop Med Hyg 1981;30: 38593.
  • 9
    Seeff LB. Natural history hepatitis C. Hepatology 1997;26 (Suppl. 1):S218.DOI: 10.1002/hep.510260704
  • 10
    Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26 (Suppl. 1):S625.DOI: 10.1002/hep.510260711
  • 11
    Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997;112: 6515.
  • 12
    Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30: 595601.
  • 13
    Darwish MA, Shaker M, Raslan O, Raouf T. Hepatitis B and D viral infections among schistosomal patients in Egypt. J Egypt Public Health Assoc 1992;67: 54763.
  • 14
    Rizkallah Y. Epidemiology of infective hepatitis in Egypt. Med J Cairo Univ 1964;32: 281.
  • 15
    Bassily S, Hyam KC, El-Masry NA, Hassan NF, Watts DM. Hepatitis C virus infection and hepatosplenic schistosomiasis. Scand J Inf Dis 1992;24: 6878.
  • 16
    Kamel MA, Miller FD, El-Masry AG et al. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 1994;88: 5019.
  • 17
    Angelico M, Renganathan E, Gandin C et al. Chronic liver disease in Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 1997;26: 23643.DOI: 10.1016/S0168-8278(97)80036-0
  • 18
    Kamal SM, Madwar MA, Bianchi L et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C coinfected with Schistosoma mansoni. Liver 2000;20: 2819.DOI: 10.1034/j.1600-0676.2000.020004281.x
  • 19
    Pereira LM, Melo MC, Saleh MG et al. Hepatitis C virus infection in schistosomiasis mansoni in Brazil. J Med Virol 1995;45: 4238.
  • 20
    Actor JK, Shirai M, Kullberg MC, Buller RML. Helminth infection results in decrease virus-CD8+ cytotoxic T-cell and TH1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993;90: 94852.
  • 21
    Marrey E, Maklad SS, El-Zyaat TA, El-Naggar BM. IL-10 in patients with combined schistosomiasis and hepatitis C virus infections. Egypt J Immunol 2000;7: 10517.
  • 22
    Kamal SM, Bianchi L, Al-Tawil A et al. Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis 2001;184: 97282.DOI: 10.1086/323352
  • 23
    Suk K, Kim SY, Kim H. Regulation of IL-18 production by IFN-γ and PGE2 in mouse microglial cells: involvement of NF-KB pathway in the regulatory processes. Immunol Lett 2001;77: 7985.DOI: 10.1016/S0165-2478(01)00209-7
  • 24
    Mee JB, Alam Y, Groves RW. Human keratinocytes constitutively produce but do not process interleukin-18. Br J Dermatol 2000;143: 3306.DOI: 10.1046/j.1365-2133.2000.03759.x
  • 25
    Katz N, Chaves A, Pellegrino J. A Simple device for quantitative stool thick smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972;14: 397400.
  • 26
    Chanczynski P, Sacchi N. Single step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162: 156.
  • 27
    Sullivan DE, Gerber MA. Conservation of hepatitis C virus 5′ untranslated sequences in hepatocellular carcinoma and the surrounding liver. Hepatology 1993;19: 551.
  • 28
    Abdel-Khalek AA, Sabry SI, Galal N, Allam MS, Fakher HA, Fahim MM. Hepatitis C virus antibodies in S. mansoni infected patients confirmed by immunoblotting (RIBA) and PCR for HCV-RNA. Egypt J Immunol 1996;3: 5762.
  • 29
    Kamal S, Madwar M, Peters T, Fawzy R, Rasenack J. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 2000;32: 1724.DOI: 10.1016/S0168-8278(00)80207-X
  • 30
    Montenegro SM, Miranda P, Mahanty S et al. Cytokine production in acute versus chronic human Schistosomiasis mansoni: the cross-regulatory role of interferon-γ and interleukin-10 in the response of peripheral blood mononuclear cells and splenocytes to parasite antigens. J Infect Dis 1999;179: 150214.DOI: 10.1086/314748
  • 31
    Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996;24: 75965.
  • 32
    Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis virus infection: implications for hepatitis C virus chronicity. Hepatology 1997;25: 44958.
  • 33
    Wodarz D, Klenerman P, Nowak MA. Dynamics of cytotoxic T-lymphocyte exhaustion. Proc R Soc Lond B Biol Sci 1998; 265: 191203.DOI: 10.1098/rspb.1998.0282
  • 34
    Hoffmann K, Cheever A, Wynn T. IL-10 and dangers of immune polarization: excessive type 1 and 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 2000;164: 640616.
  • 35
    Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999;104: 77785.
  • 36
    Farah IO, Mola PW, Kariuki TM, Nyindo M, Blanton RE, King CL. Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-β and IL-4. J Immunol 2000;164: 533743.
  • 37
    McGuinness PH, Painter D, Davies S, McCaughan GW. Increase in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000;46: 2609.DOI: 10.1136/gut.46.2.260